These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 6354507
1. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. Kofi Ekue JM, Ulrich AM, Rwabwogo-Atenyi J, Sheth UK. Bull World Health Organ; 1983; 61(4):713-8. PubMed ID: 6354507 [Abstract] [Full Text] [Related]
2. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. Ekue JM, Phiri DE, Sheth UK, Mukunyandela M. Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440 [Abstract] [Full Text] [Related]
3. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Harinasuta T, Bunnag D, Wernsdorfer WH. Bull World Health Organ; 1983; 61(2):299-305. PubMed ID: 6345013 [Abstract] [Full Text] [Related]
4. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. Ekue JM, Simooya OO, Sheth UK, Wernsdorfer WH, Njelesani EK. Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778 [Abstract] [Full Text] [Related]
5. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil. de Souza JM, Sheth UK, de Oliveira RM, Roulet H, de Souza SD. Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397 [Abstract] [Full Text] [Related]
6. A phase I clinical trial of mefloquine in Brazilian male subjects. de Souza JM. Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400 [Abstract] [Full Text] [Related]
7. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria. de Souza JM, Sheth UK, Wernsdorfer WH, Trigg PI, Doberstyn EB. Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438 [Abstract] [Full Text] [Related]
8. A phase II clinical trial of mefloquine in Brazilian male subjects. de Souza JM. Bull World Health Organ; 1983; 61(5):815-20. PubMed ID: 6360401 [Abstract] [Full Text] [Related]
9. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects. de Souza JM, Sheth UK, de Oliveira RM, Gomes AT, Cavalcante EQ. Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398 [Abstract] [Full Text] [Related]
10. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. Harinasuta T, Bunnag D, Vanijanond S, Charoenlarp P, Suntharasmai P, Chitamas S, Sheth UK, Wernsdorfer WH. Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439 [Abstract] [Full Text] [Related]
11. A comparative clinical study of mefloquine and chloroquine in the treatment of vivax malaria. Alcantara AK, Uylangco CV, Sangalang RP, Cross JH. Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):534-8. PubMed ID: 3915155 [Abstract] [Full Text] [Related]
12. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria. Fadeke Aderounmu A, Salako LA, Laoye AJ, Modupe Makinde J, Aina Adio R. Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365 [Abstract] [Full Text] [Related]
13. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. Chongsuphajaisiddhi T, Sabchareon A, Chantavanich P, Singhasivanon V, Attanath P, Wernsdorfer WH, Sheth UK. Bull World Health Organ; 1987 Dec; 65(2):223-6. PubMed ID: 3301042 [Abstract] [Full Text] [Related]
14. Response of Kampuchean strains of Plasmodium falciparum to antimalarials: in-vivo assessment of quinine and quinine plus tetracycline; multiple drug resistance in vitro. Giboda M, Denis MB. J Trop Med Hyg; 1988 Aug; 91(4):205-11. PubMed ID: 3043009 [Abstract] [Full Text] [Related]
15. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria. Silachamroon U, Krudsood S, Thanachartwet W, Tangpukdee N, Leowattana W, Chalermrut K, Srivilairit S, Wilaiaratana P, Thimasarn K, Looareesuwan S. Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422 [Abstract] [Full Text] [Related]
16. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria. Botero D, Restrepo M, Montoya A. Bull World Health Organ; 1985 May; 63(4):731-7. PubMed ID: 3910296 [Abstract] [Full Text] [Related]
17. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. Boudreau EF, Pang LW, Dixon KE, Webster HK, Pavanand K, Tosingha L, Somutsakorn P, Canfield CJ. Bull World Health Organ; 1988 May; 66(2):227-35. PubMed ID: 3293828 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria. Karbwang J, Bangchang KN, Bunnag D, Harinasuta T. Bull World Health Organ; 1991 May; 69(2):207-12. PubMed ID: 1860148 [Abstract] [Full Text] [Related]
19. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T. Bull World Health Organ; 1994 May; 72(2):233-8. PubMed ID: 8205643 [Abstract] [Full Text] [Related]
20. Response of falciparum malaria to different antimalarials in Myanmar. Ejov MN, Tun T, Aung S, Sein K. Bull World Health Organ; 1999 May; 77(3):244-9. PubMed ID: 10212515 [Abstract] [Full Text] [Related] Page: [Next] [New Search]